Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | PMP22 |
| Upstream (Parents) |
|---|
| (<<) COL6A3 → PMP22 |
| (<<) LTBP2 → PMP22 |
| (<<) RAB31 → PMP22 |
| (<<) TUBB6 → PMP22 |
| Downstream (Children) |
|---|
| PMP22 → KCNMB1 (>>) |
| PMP22 → PRKCDBP (>>) |
| PMP22 → MAP9 (>>) |
| PMP22 → MMP28 (>>) |
| PMP22 → TNFSF12 (>>) |
| PMP22 → TNFRSF4 (>>) |
| PMP22 → HAS1 (>>) |
| PMP22 → CCL2 (>>) |
| PMP22 → RAB31 (>>) |
| PMP22 → ANXA1 (>>) |
| PMP22 → VIM (>>) |
| PMP22 → CEP170 (>>) |
| PMP22 → TIMP2 (>>) |
| PMP22 → CALHM2 (>>) |
| PMP22 → GPR183 (>>) |
| PMP22 → TNFAIP8 (>>) |
| PMP22 → ARMCX1 (>>) |
| PMP22 → LXN (>>) |
| PMP22 → TUBB6 (>>) |
